Skip to main content
Livermore
Livermore
ZHEN

Intellectus Partners, LLC

SEC CIK
0001677253
Latest filing
Aug 12, 2026

IOVA holding history

Iovance Biotherapeutics, Inc. in every 13F filed by Intellectus Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IOVA overviewAll 13F holders of IOVAFull Q2 2026 holdings

Shares (Q2 2026)
151,846
Value
$631.7K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of IOVA by Intellectus Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026151,846$631.7K0.1%+15,400+11.3%AddedHolders
Q1 2026136,446$478.9K0.1%+4,000+3.0%AddedHolders
Q4 2025132,446$361.6K0.1%+1,384+1.1%AddedHolders
Q3 2025131,062$284.4K0.1%00.0%UnchangedHolders
Q2 2025131,062$225.4K<0.1%+14,850+12.8%AddedHolders
Q1 2025116,212$387.0K0.1%+1,300+1.1%AddedHolders
Q4 2024114,912$850.3K0.2%+1,583+1.4%AddedHolders
Q3 2024113,329$1.06M0.3%−600−0.5%ReducedHolders
Q2 2024113,929$913.7K0.2%−4,000−3.4%ReducedHolders
Q1 2024117,929$1.75M0.5%+1,250+1.1%AddedHolders
Q4 2023116,679$948.6K0.3%−3,600−3.0%ReducedHolders
Q3 2023120,279$547.3K0.2%+250+0.2%AddedHolders
Q2 2023120,029$845.0K0.3%+11,150+10.2%AddedHolders
Q1 2023108,879$665.2K0.2%+21,229+24.2%AddedHolders
Q4 202287,650$560.1K0.2%+41,673+90.6%AddedHolders
Q3 202245,977$440.0K0.2%00.0%UnchangedHolders
Q2 202245,977$508.0K0.2%+8,377+22.3%AddedHolders
Q1 202237,600$626.0K0.2%−2,500−6.2%ReducedHolders
Q4 202140,100$766.0K0.2%−18,700−31.8%ReducedHolders
Q3 202158,800$1.45M0.4%+750+1.3%AddedHolders
Q2 202158,050$1.51M0.3%+15,500+36.4%AddedHolders
Q1 202142,550$1.35M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.